HYDROXY AND ALKOXY SUBSTITUTED IH-IMIDAZONAPHTHYRIDINES AND METHODS
    12.
    发明申请
    HYDROXY AND ALKOXY SUBSTITUTED IH-IMIDAZONAPHTHYRIDINES AND METHODS 失效
    羟基和烷基取代的1H-咪唑并吡啶并且方法

    公开(公告)号:US20090298821A1

    公开(公告)日:2009-12-03

    申请号:US12281702

    申请日:2007-03-14

    CPC分类号: C07D471/14

    摘要: 1H-Imidazo[4,5-c]naphthyridin-4-amines with a hydroxy, alkoxy, hydroxyalkoxy, or alkoxyalkoxy substituent at the 2-position, pharmaceutical compositions containing these compounds, methods of making the compounds, intermediates, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases, are disclosed.

    摘要翻译: 在2-位具有羟基,烷氧基,羟基烷氧基或烷氧基烷氧基取代基的1H-咪唑并[4,5-c]萘啶-4-胺,含有这些化合物的药物组合物,制备化合物的方法,中间体和使用方法 的这些化合物作为免疫调节剂,用于诱导动物中的细胞因子生物合成和治疗包括病毒和肿瘤疾病的疾病。

    Amide and Carbamate Derivatives of Alkyl Substituted N-[4-(4-Amino-1H-Imidazo[4,5-C] Quinolin-1-YL)Butyl]Methanesulfonamides and Methods
    14.
    发明申请
    Amide and Carbamate Derivatives of Alkyl Substituted N-[4-(4-Amino-1H-Imidazo[4,5-C] Quinolin-1-YL)Butyl]Methanesulfonamides and Methods 失效
    烷基取代的N- [4-(4-氨基-1H-咪唑并[4,5-C]喹啉-1-YL)丁基]甲磺酰胺和方法的酰胺和氨基甲酸酯衍生物

    公开(公告)号:US20090176821A1

    公开(公告)日:2009-07-09

    申请号:US11991686

    申请日:2006-09-08

    CPC分类号: C07D471/04

    摘要: Amide and carbamate derivatives of N-[4-(4-amino-1H-imidazo[4,5-c]quinolin-1-yl)butyl]methanesulfonamides with an ethyl, methyl, or n-propyl substituent at the 2-position, pharmaceutical compositions containing these compounds, methods of making the compounds, and methods of use of these compounds in modulating the immune system, for inducing cytokine biosyn-thesis in animals and in the treatment of diseases including viral and neoplastic diseases, are disclosed.

    摘要翻译: 在2-位具有乙基,甲基或正丙基取代基的N- [4-(4-氨基-1H-咪唑并[4,5-c]喹啉-1-基)丁基]甲磺酰胺的酰胺和氨基甲酸酯衍生物 公开了含有这些化合物的药物组合物,制备该化合物的方法以及这些化合物在调节免疫系统中的用途,用于诱导动物中的细胞因子生物合成论和用于治疗包括病毒和肿瘤疾病的疾病的方法。

    Amide and carbamate derivatives of N-{2-[4-amino-2-(ethoxymethyl)-1H-imidazo[4,5-c] quinolin-1-Yl]-1,1-dimethylethyl}methanesulfonamide and methods
    16.
    发明授权
    Amide and carbamate derivatives of N-{2-[4-amino-2-(ethoxymethyl)-1H-imidazo[4,5-c] quinolin-1-Yl]-1,1-dimethylethyl}methanesulfonamide and methods 失效
    N- {2- [4-氨基-2-(乙氧基甲基)-1H-咪唑并[4,5-c]喹啉-1-基] -1,1-二甲基乙基}甲磺酰胺的酰胺和氨基甲酸酯衍生物和方法

    公开(公告)号:US08476292B2

    公开(公告)日:2013-07-02

    申请号:US11991663

    申请日:2006-09-08

    CPC分类号: C07D471/04

    摘要: Amide and carbamate derivatives N-{2-[4-amino-2-(ethoxymethyl)-1H-imidazo[4,5-c]quinolin-1-yl]-1,1-dimethylethyl}methanesulfonamide, pharmaceutical compositions containing these compounds, methods of making the compounds, and methods of use of these compounds in modulating the immune system, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases, are disclosed.

    摘要翻译: 酰胺和氨基甲酸酯衍生物N- {2- [4-氨基-2-(乙氧基甲基)-1H-咪唑并[4,5-c]喹啉-1-基] -1,1-二甲基乙基}甲磺酰胺,含有这些化合物的药物组合物 公开了制备化合物的方法,以及这些化合物在调节免疫系统中的用途,用于在动物中诱导细胞因子生物合成和治疗包括病毒和肿瘤疾病的疾病的方法。

    Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds
    19.
    发明授权
    Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds 有权
    取代的手性稠合[1,2]咪唑并[4,5-c]环化合物

    公开(公告)号:US08034938B2

    公开(公告)日:2011-10-11

    申请号:US11813052

    申请日:2005-12-29

    CPC分类号: C07D471/04 C07D471/14

    摘要: Substituted fused [1,2]imidazo[4,5-c] ring compounds (e.g., imidazo[4,5-c]quinolines, 6,7,8,9-tetrahydroimidazo[4,5-c]quinolines, imidazo[4,5-c]naphthyridines, and 6,7,8,9-tetrahydroimidazo[4,5-c]naphthyridines) with a —CH(—R1)— group in the fused ring at the 1-position of the imidazo ring, wherein R1 includes a functional group, for example, an amide, sulfonamide, urea, carbamate, ester, ketone, ether, a thio analog of the forgoing, sulfone, oxime, or hydroxylamine, pharmaceutical compositions containing the compounds, intermediates, methods of making the compounds, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases, are disclosed.

    摘要翻译: 取代的稠合[1,2]咪唑并[4,5-c]环化合物(例如咪唑并[4,5-c]喹啉,6,7,8,9-四氢咪唑并[4,5-c]喹啉,咪唑并[ 4,5-c]萘啶和6,7,8,9-四氢咪唑并[4,5-c]萘啶)在咪唑环1位的稠环中具有-CH(-R1) - 基 其中R1包括官能团,例如酰胺,磺酰胺,脲,氨基甲酸酯,酯,酮,醚,前述砜,肟或羟胺的硫代类似物,含有这些化合物的药物组合物,中间体, 公开了使这些化合物和这些化合物用作免疫调节剂的方法,用于诱导动物中的细胞因子生物合成和治疗包括病毒和肿瘤疾病的疾病。